Pharmala Biotech Holdings Inc. (MDMA) — research page
CA · ca-cm-kg/CSE/MDMA · as of 2026-11-06
Identity and listing
The issuer is Pharmala Biotech Holdings Inc., listed on the CSE under ticker MDMA, with ISIN CA71719L1067 and LEI 25490067ZSSSB85I9Y16. Its security type is Corporate, its segment is not on the record, its sector is Life Sciences, and its jurisdiction is Ontario (CA-ON). The listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Pharmala Biotech Holdings Inc. | source · 2026-11-06 |
| exchange | CSE | source · 2026-11-06 |
| ticker | MDMA | source · 2026-11-06 |
| ISIN | CA71719L1067 | source · 2026-11-06 |
| LEI | 25490067ZSSSB85I9Y16 | source · 2026-11-06 |
| security type | Corporate | source · 2026-11-06 |
| segment | not on the record | |
| sector | Life Sciences | source · 2026-11-06 |
| jurisdiction | Ontario (CA-ON) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 7 filings in the twelve months to 2026-11-06, on 6 filing days, all of them newswire releases. The median gap between filing days is 28 days. The latest filing is dated 2026-11-05, 1 day before the record date, and is a newswire release. The CSE median gap is 19.5 days across 724 issuers, with a median of 6.0 filings and a median latency of 17.0 days. The Life Sciences sector median gap is 17.5 days across 200 issuers, with a median of 7.0 filings and a median latency of 14 days.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 7 | 28 | 1 |
| exchange median: CSE (724 issuers) | 6 | 19.5 | 17 |
| sector median: Life Sciences (200 issuers) | 7 | 17.5 | 14 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-05 | newswire_release | PharmAla Signs Agreement and Initiates R&D with Corealis | |
| 2026-10-08 | newswire_release | Rua Bioscience and PharmAla Biotech partner to supply | |
| 2026-09-17 | newswire_release | PharmAla Biotech Provides Corporate Update: Change of | |
| 2026-04-20 | newswire_release | PharmAla Biotech Positioned to Supply U.S. Expanded Access | |
| 2026-04-20 | newswire_release | PharmAla Biotech Positioned to Supply U.S. Expanded Access |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is Clearhouse LLP, and its location is not on the record. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting, name change, domicile change or segment move lines. The halt flag is listed, not halted.
Orderability
Under the rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, the outcome for the client category Paragraph (o) of the definition is signal ACM-200, determinable. The outcome for the client category Paragraph (q) of the definition is signal ACM-200, determinable. The chapter is as of 2026-11-04.
| client category | outcome |
|---|---|
| Paragraph (o) of the definition | ACM-200 |
| Paragraph (q) of the definition | ACM-200 |
rule acm-68000/ca/kyp-know-your-product-ni-31-103/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The field has not been read. The number of research houses named on the issuer's investor-relations page is not on the record.
Open research
The field has not been read. The number of openly published research notes is not on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. The issuer has no sealed years on the record. The live record began on 2026-09-10. Years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but not served as of a date, and the as-of answer is not_sealed.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://thecse.com/api/webapi/listed-companies/ (identity.exchange)
- 10.2
- https://www.marketscreener.com/quote/stock/PHARMALA-BIOTECH-HOLDINGS-131624716/company (identity.isin)
- 10.3
- https://api.gleif.org/api/v1/lei-records/25490067ZSSSB85I9Y16 (identity.jurisdiction)
- 10.4
- https://mcp.ca-cm-kg.ai/events/CSE/MDMA (the disclosure lines)
- 10.5
- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)
- 10.6
- https://thecse.com/listings/pharmala-biotech-holdings-inc/ (the auditor)
- 10.7
- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://mcp.ca-cm-kg.ai/record/CSE/MDMA (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"CA71719L1067"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:e7bccb59573126e1.